The first panel comprised of 3 proteins: afamin, alpha-2-HS-glycoprotein chain B and fibronectin 1 (shown in red font), and was seen to be relatively increased in expression in the non-progressing versus the BPH group, but decreased as the cancer progressed and remained relatively low as the cancer metastasized. The gene discussed is AFM; the disease is cancer.